Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI

Neurology

Volumn 84, Issue 12, 2015, Pages 1261-1268

  Wolfsgruber, Steffen ^a,b   Jessen, Frank ^a,b,t   Koppara, Alexander ^a,b   Kleineidam, Luca ^a,b   Schmidtke, Klaus ^c   Frölich, Lutz ^d   Kurz, Alexander ^e   Schulz, Stefanie ^f,g   Hampel, Harald ^h,i,j   Heuser, Isabella ^k   Peters, Oliver ^k   Reischies, Friedel M ^k   Jahn, Holger ^l   Luckhaus, Christian ^m   Hüll, Michael ⁿ   Gertz, Hermann Josef ^o   Schröder, Johannes ^p   Pantel, Johannes ^q   Rienhoff, Otto ^g   Rüther, Eckart ^g   Henn, Fritz ^r   Wiltfang, Jens ^g   Maier, Wolfgang ^a,b   Kornhuber, Johannes ^s   Wagner, Michael ^a,b   more..

^a UNIVERSITY OF BONN   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c Ortenau Klinikum   (Germany)

^d CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f RWTH AACHEN UNIVERSITY   (Germany)

^g UNIVERSITY OF GÖTTINGEN   (Germany)

^h AXA   (France)

ⁱ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^j INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^k CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^l UNIVERSITY OF HAMBURG   (Germany)

^m HEINRICH HEINE UNIVERSITY   (Germany)

ⁿ UNIVERSITY OF FREIBURG   (Germany)

^o UNIVERSITY OF LEIPZIG   (Germany)

^p UNIVERSITY OF HEIDELBERG   (Germany)

^q GOETHE UNIVERSITY   (Germany)

^r BROOKHAVEN NATIONAL LABORATORY   (United States)

^s UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^t UNIVERSITY OF COLOGNE   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; TAU PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

AGED; ALZHEIMER DISEASE; ARTICLE; ASSESSMENT OF HUMANS; CEREBROSPINAL FLUID ANALYSIS; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DEPRESSION; DESCRIPTIVE RESEARCH; EDUCATIONAL STATUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; SUBJECTIVE COGNITIVE DECLINE; SUBJECTIVE MEMORY DECLINE SCALE; VERBAL MEMORY; CEREBROSPINAL FLUID; CLINICAL TRIAL; MIDDLE AGED; PATHOPHYSIOLOGY; PRODROMAL SYMPTOM; PSYCHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PEPTIDE FRAGMENTS; PRODROMAL SYMPTOMS; TAU PROTEINS;

EID: 84925424278     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001399     Document Type: Article

References (40)

1. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment: beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240-246.
2. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183-194.
3. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7: 270-279.
4. Wagner M, Wolf S, Reischies FM, et al. Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. Neurology 2012;78:379-386.
5. Dubois B, Feldman HH, Jacova C, et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol 2014;13:614-629.
6. Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:280-292.
7. Visser PJ, Verhey F, Knol DL, et al. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA Study. A prospective cohort study. Lancet Neurol 2009;8:619-627.
8. Mosconi L, De Santi S, Brys M, et al. Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints. Biol Psychiatry 2008;63:609-618.
9. Amariglio RE, Becker JA, Carmasin J, et al. Subjective cognitive complaints and amyloid burden in cognitively normal older individuals. Neuropsychologia 2012;50: 2880-2886.
10. Mielke MM, Wiste HJ, Weigand SD, et al. Indicators of amyloid burden in a population-based study of cognitively normal elderly. Neurology 2012;79:1570-1577.
11. Saykin AJ, Wishart HA, Rabin LA, et al. Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology 2006;67:834-842.
12. Rami L, Fortea J, Bosch B, et al. Cerebrospinal fluid biomarkers and memory present distinct associations along the continuum from healthy subjects to AD patients. J Alzheimers Dis 2011;23:319-326.
13. Jessen F, Amariglio RE, van Boxtel M, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement 2014; 10:844-852.
14. Roberts JL, Clare L, Woods RT. Subjective memory complaints and awareness of memory functioning in mild cognitive impairment. A systematic review. Dement Geriatr Cogn Disord 2009;28:95-109.
15. Vogel A, Stokholm J, Gade A, Andersen BB, Hejl A, Waldemar G. Awareness of deficits in mild cognitive impairment and Alzheimer's disease: do MCI patients have impaired insight? Dement Geriatr Cogn Disord 2004;17: 181-187.
16. Snitz BE, Morrow LA, Rodriguez EG, Huber KA, Saxton JA. Subjective memory complaints and concurrent memory performance in older patients of primary care providers. J Int Neuropsychol Soc 2008;14:1004-1013.
17. Grambaite R, Hessen E, Auning E, Aarsland D, Selnes P, Fladby T. Correlates of subjective and mild cognitive impairment: depressive symptoms and CSF biomarkers. Dement Geriatr Cogn Dis Extra 2013;3:291-300.
18. Reid LM, MacLullich AM. Subjective memory complaints and cognitive impairment in older people. Dement Geriatr Cogn Disord 2006;22:471-485.
19. Stern Y. Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol 2012;11:1006-1012.
20. Kornhuber J, Schmidtke K, Frölich L, et al. Early and differential diagnosis of dementia and mild cognitive impairment. Dement Geriatr Cogn Disord 2009;27: 404-417.
21. Lewczuk P, Kornhuber J, Wiltfang J. The German Competence Net Dementias: standard operating procedures for the neurochemical dementia diagnostics. J Neural Transm 2006;113:1075-1080.
22. Lewczuk P, Esselmann H, Otto M, et al. Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/ Abeta40 ratio and total tau. Neurobiol Aging 2004; 25:273-281.
23. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
24. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8: 271-276.
25. Wechsler D. WMS-R: Wechsler Memory Scale-Revised Manual. San Antonio: Psychological Corporation; 1987.
26. Buschke H. Cued recall in amnesia. J Clin Exp Neuropsychol 1984;6:433-440.
27. Wolfsgruber S, Jessen F, Wiese B, et al. The CERAD neuropsychological assessment battery total score detects and predicts Alzheimer disease dementia with high diagnostic accuracy. Am J Geriatr Psychiatry 2013;22:1017-1028.
28. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134: 382-389.
29. Müller MJ, Himmerich H, Kienzle B, Szegedi A. Differentiating moderate and severe depression using the Montgomery-?sberg Depression Rating Scale (MADRS). J Affect Disord 2003;77:255-260.
30. Hindmarch I, Lehfeld H, de Jongh P, Erzigkeit H. The Bayer Activities of Daily Living Scale (B-ADL). Dement Geriatr Cogn Disord 1998;9(suppl 2):20-26.
31. Jorm AF, Christensen H, Korten AE, Henderson AS, Jacomb PA, Mackinnon A. Do cognitive complaints either predict future cognitive decline or reflect past cognitive decline? A longitudinal study of an elderly community sample. Psychol Med 1997;27:91-98.
32. Jessen F, Wolfsgruber S, Wiese B, et al. AD dementia risk in late MCI, in early MCI, and in subjective memory impairment. Alzheimers Dement 2014;10:76-83.
33. Wolfsgruber S, Wagner M, Schmidtke K, et al. Memory concerns, memory performance and risk of dementia in patients with mild cognitive impairment. PLoS One 2014; 9:e100812.
34. Chandler MJ, Lacritz LH, Hynan LS, et al. A total score for the CERAD neuropsychological battery. Neurology 2005;65:102-106.
35. Crowe M, Andel R, Wadley V, et al. Subjective cognitive function and decline among older adults with psychometrically defined amnestic MCI. Int J Geriatric Psychiatry 2006;21:1187-1192.
36. Dumurgier J, Paquet C, Benisty S, et al. Inverse association between CSF Ab 42 levels and years of education in mild form of Alzheimer's disease: the cognitive reserve theory. Neurobiol Dis 2010;40:456-459.
37. van Harten AC, Visser PJ, Pijnenburg YAL, et al. Cerebrospinal fluid Ab42 is the best predictor of clinical progression in patients with subjective complaints. Alzheimers Dement 2013;9:481-487.
38. Aisen PS, Petersen RC, Donohue MC, et al. Clinical core of the Alzheimer's disease neuroimaging initiative: progress and plans. Alzheimers Dement 2010;6:239-246.
39. Dickerson BC, Sperling RA, Hyman BT, Albert MS, Blacker D. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Arch Gen Psychiatry 2007;64:1443-1450.
40. Buckley RF, Ellis KA, Ames D, et al. Phenomenological characterization of memory complaints in preclinical and prodromal Alzheimer's disease. Neuropsychology Epub ahead of print 2015 Feb 9.